Andersen L, Vølund A, Olsen K J, Plum A, Walsh D
Novo Nordisk A/S, Novo Allé, Bagsvaerd, Denmark.
J Immunoassay Immunochem. 2001;22(2):147-63. doi: 10.1081/IAS-100103226.
A radioimmunoassay (RIA) for insulin was validated for reliable measurement of the human insulin analogue, insulin aspart, by correction of non-linear measurements. Specificity was equivalent for several species of insulin, except insulin aspart. A non-linear hyperbolic model fitted insulin aspart with a correction formula for non-linearity of: z = 1,503y/ (1,398 - y), where y denotes measured concentration and z denotes true concentration. Matrix-effects were insignificant for human, porcine, and canine heparin-plasma and for human and porcine serum. The coefficient of variation was below 15% for 80-800 pmol/L human and porcine insulin and for 80-600 pmol/L insulin aspart. The limit of detection for insulin aspart was 11.5 pmol/L with a lower limit of quantification of 17.5 pmol/ L. Dilution of serum with Pharmacia dilution media introduced no significant error. In conclusion, this paper demonstrates that a non-parallel radioimmunoassay can be used to estimate accurate concentrations of insulin aspart.
通过对非线性测量值进行校正,验证了一种用于胰岛素的放射免疫分析(RIA)方法可可靠地测定人胰岛素类似物门冬胰岛素。除门冬胰岛素外几种胰岛素的特异性相当。用非线性双曲线模型拟合门冬胰岛素,其非线性校正公式为:z = 1,503y / (1,398 - y),其中y表示测量浓度,z表示真实浓度。人、猪和犬的肝素血浆以及人血清和猪血清的基质效应不显著。80 - 800 pmol/L的人胰岛素和猪胰岛素以及80 - 600 pmol/L的门冬胰岛素的变异系数低于15%。门冬胰岛素的检测限为11.5 pmol/L,定量下限为17.5 pmol/L。用Pharmacia稀释介质稀释血清不会引入显著误差。总之,本文证明非平行放射免疫分析可用于准确估计门冬胰岛素的浓度。